ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

NIH Carcinogen Guidelines Offered

April 24, 1981

NCA Approves New Guidelines For Comprehensive Review

December 8, 1989

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions

November 6, 1981